Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Cisplatin ototoxicity and otoprotection with sodium salicylate (2006)

  • Authors:
  • USP affiliated authors: HYPPOLITO, MIGUEL ANGELO - FMRP ; OLIVEIRA, JOSE A. A. - FMRP
  • USP Schools: FMRP; FMRP
  • DOI: 10.1007/s00405-006-0070-6
  • Subjects: OTORRINOLARINGOLOGIA; ANTINEOPLÁSICOS
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/s00405-006-0070-6 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: European Archives of Oto-Rhino-Laryngology

    ISSN: 0937-4477

    Citescore - 2017: 1.54

    SJR - 2017: 0.8

    SNIP - 2017: 1.061


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FMRP11200049406-Spcd 1551710
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      HYPPOLITO, Miguel Angelo; OLIVEIRA, José Antonio Apparecido de; ROSSATO, Maria. Cisplatin ototoxicity and otoprotection with sodium salicylate. European Archives of Otorhinolaryngoly, Heidelberg, v. 263, n. 9, p. 798-803, 2006. DOI: 10.1007/s00405-006-0070-6.
    • APA

      Hyppolito, M. A., Oliveira, J. A. A. de, & Rossato, M. (2006). Cisplatin ototoxicity and otoprotection with sodium salicylate. European Archives of Otorhinolaryngoly, 263( 9), 798-803. doi:10.1007/s00405-006-0070-6
    • NLM

      Hyppolito MA, Oliveira JAA de, Rossato M. Cisplatin ototoxicity and otoprotection with sodium salicylate. European Archives of Otorhinolaryngoly. 2006 ; 263( 9): 798-803.
    • Vancouver

      Hyppolito MA, Oliveira JAA de, Rossato M. Cisplatin ototoxicity and otoprotection with sodium salicylate. European Archives of Otorhinolaryngoly. 2006 ; 263( 9): 798-803.

    Referências citadas na obra
    Towflight J, Strauss M, Lord S (1983) Cisplatin ototoxicity: clinical experience and temporal bone histopathology. Laryngoscope 93:1554–1559
    Piel IJ, Meyer D, Percia CP, Wolfe VI (1974) Effects of cis-diamminedichloroplatinum (NSC-119875) on hearing function in man. Cancer Chemother Rep 58:871–875
    Laurell G, Engström B (1989) The ototoxic effect of cisplatin in guinea pigs in relation to dosage. Hearing Res 38:27–34
    Cardinaal RM, Groot JCMJ, Huizing EH, Veldman JE, Smoorenburg GF (2000) Dose-dependent effect of 8-day cisplatin administration upon the morphology of the albino guinea pig cochlea. Hearing Res 144:135–146
    Stengs CHM, Klis SFL, Huizing EH, Smoorenburg GF (1998) Cisplatin ototoxicity: an electrophysiological dose–effect study in albino guinea pigs. Hearing Res 124:99–107
    Mcalpine D, Johnstone BM (1990) The ototoxic mechanism of cisplatin. Hearing Res 47:191–203
    Ravi R, Somani SM, Rybak LP (1995) Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol Toxicol 76:386–394
    Ikeda K, Sunose H, Takasaka (1993) Effects of free radicals on the intracellular calcium concentration in the isolated outer hair cell of the guinea pig cochlea. Acta Otolaryngol (Stock) 113:137–141
    Blakley BW, Cohen JI, Doolittle ND, Muldoon LL, Campbell KC, Dickey DT, Neuwelt EA (2002) Strategies for prevention of toxicity caused by platinum-based chemotherapy: review and summary of the annual meeting of the blood–brain barrier disruption program, Gleneden Beach, Oregon, March 10, 2001. Laryngoscope 112:1997–2001
    Rybak LP, Somani S (1999) Ototoxicity: amelioration by protective agents. Ann NY Acad Sci 884:143–151
    Rybak LP, Whitworth MA, Somani S (1999) Application of antioxidants and other agents to prevent cisplatin ototoxicity. Laryngoscope 109:1740–1744
    Evans P, Halliwell B (1999) Free radicals and hearing: cause, consequence, and criteria. Ann NY Acad Sci 28:19–40
    Sha SH, Schacht J (1999) Salicylate attenuates gentamicin induced ototoxicity. Lab Invest 79:807–813
    Song BB, Schacht J (1996) Variable efficacy of radical scavengers and iron chelators to attenuate gentamicin ototoxicity in guinea pig in vivo. Hearing Res 94:87–93
    Li G, Sha SH, Zotova E, Arezzo J, Van De Water T, Schacht J (2002) Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action. Lab Invest 82:585–596
    Yung MW, Dorman EB (1986) Electrocochleography during intravenous infusion of cisplatin. Arch Otolaryngol Head Neck Surg 112:823–826
    Coupland SG, Ponton CW, Eggermont JJ, Bowen TJ, Grant RM (1991) Assessment of cisplatin-induced ototoxicity using derived band ABRs. Int J Pediatr Otorhinolaryngol 22:237–248
    Sie KC, Norton SJ (1997) Changes in otoacoustic emissions and auditory brainstem response after cisplatinum exposure in gerbils. Otolaryngol Head Neck Surg 116:585–592
    Cevette MJ, Drew D, Webb TM, Marion MS (2000) Cisplatin ototoxicity, increased DPOAE amplitudes, and magnesium deficiency: distortion product otoacoustic emissions. J Am Acad Audiol 11:323–329
    Harel N, Kakigi A, Hirakawa H, Mount RJ, Harrison RV (1997) The effects of anesthesia on otoacoustic emissions. Hearing Res 110:25–33
    Sockalingam R, Freeman S, Cherny TL, Sohmer H (2000) Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals. Am J Otol 21:521–527
    Preyer W (1882) Die Seele des Kindes. Grieben, Leipzig
    He NJ, Schmiedt RA (1993) Fine structure of the 2F1–F2 acoustic distortion product: changes with primary level. J Acoust Soc Am 94:2659–2669
    Saito T, Manabe Y, Honda N, Yamada T, Yamamoto T, Saito H (1995) Semiquantitative analysis by scanning electron microscopy of cochlear hair cell damage by ototoxic drugs. Scanning Microsc 9:271–281
    Jastreboff PJ, Sasaki CT (1994) An animal model of tinnitus: a decade of development. Am J Otol 15:19–27
    Garetz SL, Schacht J (1996) Ototoxicity: of mice and men. In: Van De Water TR, Popper AN, Fay RR (eds) Clinical aspects of hearing. Springer, New York pp 16–154